Neurodegeneration: Autophagy

Given that progression of neurodegenerative diseases can be driven by aggregation of misfolded proteins, autophagic activity is through to modulate the severity of neurodegenerative diseases. Here is the latest research on the influence of autophagy on neurodegeneration.

January 21, 2022
Open Access

Autophagy of the Nucleus in Health and Disease.

Frontiers in Cell and Developmental Biology
Georgios Konstantinidis, Nektarios Tavernarakis
January 20, 2022

Liraglutide Regulates Mitochondrial Quality Control System Through PGC-1α in a Mouse Model of Parkinson's Disease.

Neurotoxicity Research
Pengyue WuYanqin Wang
January 19, 2022
Open Access

Idebenone improves motor dysfunction, learning and memory by regulating mitophagy in MPTP-treated mice.

Cell Death Discovery
Junqiang YanJiannan Wu
January 19, 2022

A cerebrospinal fluid microRNA analysis: Progressive supranuclear palsy.

Molecular Medicine Reports
Wakako NonakaTsutomu Masaki
January 19, 2022

mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis.

Movement Disorders : Official Journal of the Movement Disorder Society
Jose-Alberto PalmaHoracio Kaufmann
January 17, 2022

The Role of ERK1/2 Pathway in the Pathophysiology of Alzheimer's Disease: An Overview and Update on New Developments.

Cellular and Molecular Neurobiology
Mohammad Rafi KhezriMorteza Ghasemnejad-Berenji
January 17, 2022
Open Access

Effects of Polyphenols on Oxidative Stress, Inflammation, and Interconnected Pathways during Spinal Cord Injury.

Oxidative Medicine and Cellular Longevity
Sajad FakhriJianbo Xiao
January 15, 2022

Chronic lithium administration in a mouse model for Krabbe disease.

JIMD Reports
Ambra Del GrossoMarco Cecchini
January 15, 2022

The complex interplay between autophagy and cell death pathways.

The Biochemical Journal
Christina PloumiNektarios Tavernarakis
January 15, 2022

Neuroprotective effect of YIAEDAER peptide against Parkinson's disease like pathology in zebrafish.

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Qingyu RenMeng Jin
January 14, 2022

Inhibiting mitochondrial fission rescues degeneration in hereditary spastic paraplegia neurons.

Brain : a Journal of Neurology
Zhenyu ChenXue-Jun Li
January 14, 2022

Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy.

Brain : a Journal of Neurology
Yu Young JeongQian Cai
January 12, 2022
Open Access

Neurodegeneration and Astrogliosis in the Human CA1 Hippocampal Subfield Are Related to hsp90ab1 and bag3 in Alzheimer's Disease.

International Journal of Molecular Sciences
Melania Gonzalez-RodriguezDaniel Saiz-Sanchez
January 12, 2022
Open Access

Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges.

International Journal of Molecular Sciences
Francesco AgostiniMarco Bisaglia
January 12, 2022
Open Access

Covering the Role of PGC-1α in the Nervous System.

Zuzanna KuczynskaLeonora Buzanska
January 12, 2022

Screening the Efficacy of Melatonin on Neurodegeneration Mediated by Endoplasmic Reticulum Stress, Inflammation, and Oxidative Damage.

Applied Biochemistry and Biotechnology
Fathima Hajee Basha, S Hemalatha

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

© 2022 Meta ULC. All rights reserved